Figures and Tables

From the following article:

Gefitinib — a novel targeted approach to treating cancer

Roy S. Herbst, Masahiro Fukuoka & José Baselga

Nature Reviews Cancer 4, 979-987 (December 2004)

doi:10.1038/nrc1506

Figure 1 - Gefitinib |[mdash]| a novel targeted approach to treating cancer

Figure 1

The epidermal growth factor receptor signalling pathway.

Figure 2 - Gefitinib |[mdash]| a novel targeted approach to treating cancer

Figure 2

The epidermal growth factor receptor.

Table 1 - Gefitinib |[mdash]| a novel targeted approach to treating cancer

Table 1

EGFR-targeted agents

Table 2 - Gefitinib |[mdash]| a novel targeted approach to treating cancer

Table 2

Summary of results from Phase II IDEAL trials

Table 3 - Gefitinib |[mdash]| a novel targeted approach to treating cancer

Table 3

Gefitinib trials underway in patients with non-small-cell lung cancer